Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
$185M |
| 3 |
WESCO International
WCC
|
$171M |
| 4 |
Gilead Sciences
GILD
|
$158M |
| 5 |
Delta Air Lines
DAL
|
$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$221M |
| 2 |
3M
MMM
|
$154M |
| 3 |
Marsh & McLennan
MMC
|
$115M |
| 4 |
Johnson & Johnson
JNJ
|
$99M |
| 5 |
Novo Nordisk
NVO
|
$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
AGNC Investment
AGNC
$10.6B
| – | – |
-250,000
| Closed | -$2.62M |
|
877
Abercrombie & Fitch
ANF
$4.4B
| – | – |
-90,000
| Closed | -$12.6M |
|
878
Annexon
ANNX
$236M
| – | – |
-2,840,145
| Closed | -$16.8M |
|
879
Apple Hospitality REIT
APLE
$3.09B
| – | – |
-275,000
| Closed | -$4.08M |
|
880
Alexandria Real Estate Equities
ARE
$14.2B
| – | – |
-1,700
| Closed | -$202K |
|
881
Arrowhead Research
ARWR
$3.87B
| – | – |
-350,000
| Closed | -$6.78M |
|
882
Ascendis Pharma
ASND
$12B
| – | – |
-486,957
| Closed | -$72.7M |
|
|
AUTL
883
Autolus Therapeutics
AUTL
$386M
| – | – |
-2,950,000
| Closed | -$10.7M |
|
884
Ball Corp
BALL
$13.7B
| – | – |
-288,322
| Closed | -$19.6M |
|
885
Bally's
BALY
$491M
| – | – |
-127,144
| Closed | -$2.19M |
|
886
Baxter International
BAX
$12.1B
| – | – |
-1,563,567
| Closed | -$59.4M |
|
887
Brink's
BCO
$4.74B
| – | – |
-20,839
| Closed | -$2.41M |
|
888
Franklin Resources
BEN
$13.4B
| – | – |
-265,900
| Closed | -$5.36M |
|
889
Biogen
BIIB
$20.5B
| – | – |
-45,799
| Closed | -$8.88M |
|
890
TopBuild
BLD
$12.1B
| – | – |
-5,000
| Closed | -$2.03M |
|
891
BioNTech
BNTX
$24.9B
| – | – |
-57,500
| Closed | -$6.83M |
|
892
Bolt Biotherapeutics
BOLT
$9.29M
| – | – |
-25,000
| Closed | -$324K |
|
893
Perspective Therapeutics
CATX
$263M
| – | – |
-750,000
| Closed | -$10M |
|
894
Century Aluminum
CENX
$2.06B
| – | – |
-10,000
| Closed | -$162K |
|
895
Citizens Financial Group
CFG
$22.7B
| – | – |
-62,619
| Closed | -$2.57M |
|
896
Campbell Soup
CPB
$9.74B
| – | – |
-43,346
| Closed | -$2.12M |
|
897
Capri Holdings
CPRI
$2.59B
| – | – |
-749,133
| Closed | -$31.8M |
|
898
CRH
CRH
$74.9B
| – | – |
-222,000
| Closed | -$20.6M |
|
899
CervoMed
CRVO
$88.9M
| – | – |
-28,600
| Closed | -$418K |
|
900
CytomX Therapeutics
CTMX
$346M
| – | – |
-3,000,000
| Closed | -$3.54M |
|